Daniel Serón
Impact in
- Transplantation top 0.01%
- Renal Transplantation Outcomes and Treatments
- Nephrology top 0.5%
- Chronic Kidney Disease and Diabetes
- Renal Diseases and Glomerulopathies
Papers in
- Transplantation 195
- Renal Transplantation Outcomes and Treatments 195
- Nephrology 48
- Renal Diseases and Glomerulopathies 23
- Chronic Kidney Disease and Diabetes 21
- Acute Kidney Injury Research 11
- Co-authors
- Francesc Moreso (122 shared papers)Josep Maria Grinyo (44 shared papers)Xavier Fulladosa (24 shared papers)Salvador Gil‐Vernet (43 shared papers)Josep Maria Cruzado (26 shared papers)Miguel Hueso (20 shared papers)Joan Torrás (27 shared papers)Meritxell Ibernón (21 shared papers)
- Journals
- Transplantation (30 papers)American Journal of Transplantation (22 papers)Nephrology Dialysis Transplantation (19 papers)Kidney International (14 papers)Clinical Kidney Journal (12 papers)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
Daniel Serón
275 papers receiving 14.6k citations
Daniel Serón's Hit Papers
Peers
Comparison fields: 5 of 122
- Transplantation 9.7k
- Nephrology 2k
- Immunology 736
- Surgery 1.4k
- Family Practice 72
Countries citing papers authored by Daniel Serón
This map shows the geographic impact of Daniel Serón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Serón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Serón more than expected).
Fields of papers citing papers by Daniel Serón
This network shows the impact of papers produced by Daniel Serón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Serón. The network helps show where Daniel Serón may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Serón, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 284 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions Hit paper breakdown → | 2008 | 1600 |
| 2 | Antibody-Mediated Rejection Criteria - an Addition to the Banff ’97 Classification of Renal Allograft Rejection Hit paper breakdown → | 2003 | 905 |
| 3 | Banff ’05 Meeting Report: Differential Diagnosis of Chronic Allograft Injury and Elimination of Chronic Allograft Nephropathy (’CAN’) Hit paper breakdown → | 2007 | 904 |
| 4 | The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials Hit paper breakdown → | 2017 | 828 |
| 5 | The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection Hit paper breakdown → | 2020 | 639 |
| 6 | Banff ’09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working Groups Hit paper breakdown → | 2010 | 628 |
| 7 | The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology Hit paper breakdown → | 2016 | 537 |
| 8 | Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial Hit paper breakdown → | 2019 | 527 |
| 9 | 2006 | 262 | |
| 10 | Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group Hit paper breakdown → | 2019 | 256 |
| 11 | Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients Hit paper breakdown → | 2017 | 244 |
| 12 | 1997 | 219 | |
| 13 | 1990 | 196 | |
| 14 | 2003 | 193 | |
| 15 | 2003 | 184 | |
| 16 | 2014 | 183 | |
| 17 | Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis Hit paper breakdown → | 2022 | 170 |
| 18 | 1991 | 155 | |
| 19 | 2017 | 155 | |
| 20 | 2017 | 152 |
About Daniel Serón
Daniel Serón is a scholar working on Transplantation, Nephrology, Cardiology and Cardiovascular Medicine, Surgery and Public Health, Environmental and Occupational Health, having authored 284 papers that have together received 15k indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (195 papers), Renal Diseases and Glomerulopathies (23 papers), Chronic Kidney Disease and Diabetes (21 papers), Organ Donation and Transplantation (12 papers), Acute Kidney Injury Research (11 papers), Organ Transplantation Techniques and Outcomes (9 papers), Blood Pressure and Hypertension Studies (6 papers) and COVID-19 Clinical Research Studies (6 papers). The work is most often cited by research in Transplantation (9.7k citations), Nephrology (2k citations), Immunology (736 citations), Surgery (1.4k citations) and Family Practice (72 citations). Daniel Serón has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Francesc Moreso, Josep Maria Grinyo, Xavier Fulladosa, Salvador Gil‐Vernet, Josep Maria Cruzado, Miguel Hueso, Joan Torrás, Meritxell Ibernón, Richard Hartley and Efstathios Alexopoulos. Their work appears in journals such as Transplantation, American Journal of Transplantation, Nephrology Dialysis Transplantation, Kidney International and Clinical Kidney Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.